{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2020:OZTP7DUMDPT2RLDK4T27QT4PMZ","short_pith_number":"pith:OZTP7DUM","schema_version":"1.0","canonical_sha256":"7666ff8e8c1be7a8ac6ae4f5f84f8f666c492d0dd44ea44f129cf1626d0dee9d","source":{"kind":"arxiv","id":"2012.05716","version":2},"attestation_state":"computed","paper":{"title":"Utilising Graph Machine Learning within Drug Discovery and Development","license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","headline":"","cross_cats":["cs.LG"],"primary_cat":"q-bio.QM","authors_text":"Arian R. Jamasb, Ben Day, Charles Roberts, Cristian Regep, David Roblin, Gertrude Liu, Jake P. Taylor-King, Jeremy B. R. Hayter, Jian Tang, Jyothish Soman, Michael M. Bronstein, Richard Vickers, Thomas Gaudelet, Tom L. Blundell","submitted_at":"2020-12-09T10:12:33Z","abstract_excerpt":"Graph Machine Learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst other data types. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development. After introducing key terms and modelling approaches, we move chronologically through the drug development pipeline to identify and summarise work incorporating: target identification, design of sma"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2012.05716","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","primary_cat":"q-bio.QM","submitted_at":"2020-12-09T10:12:33Z","cross_cats_sorted":["cs.LG"],"title_canon_sha256":"76c2c5fe2f037ceef7e98b3890f920e2acdaee6d7e9dda6f5d3d3f6765d9ad8b","abstract_canon_sha256":"625a51e49a76c599e1b91623ebeedb942a813143a088887646b287299fa9348d"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T02:14:12.990310Z","signature_b64":"FA0plJkM4y5svx7i8oibPjtB+TXBbJZyhzoII60Pqqap3zOWvbjS7ZMUnr/71Zgvm4HwYQ5+pjBTp11s2rm1Cw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"7666ff8e8c1be7a8ac6ae4f5f84f8f666c492d0dd44ea44f129cf1626d0dee9d","last_reissued_at":"2026-07-05T02:14:12.989693Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T02:14:12.989693Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Utilising Graph Machine Learning within Drug Discovery and Development","license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","headline":"","cross_cats":["cs.LG"],"primary_cat":"q-bio.QM","authors_text":"Arian R. Jamasb, Ben Day, Charles Roberts, Cristian Regep, David Roblin, Gertrude Liu, Jake P. Taylor-King, Jeremy B. R. Hayter, Jian Tang, Jyothish Soman, Michael M. Bronstein, Richard Vickers, Thomas Gaudelet, Tom L. Blundell","submitted_at":"2020-12-09T10:12:33Z","abstract_excerpt":"Graph Machine Learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst other data types. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development. After introducing key terms and modelling approaches, we move chronologically through the drug development pipeline to identify and summarise work incorporating: target identification, design of sma"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2012.05716","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2012.05716/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2012.05716","created_at":"2026-07-05T02:14:12.989767+00:00"},{"alias_kind":"arxiv_version","alias_value":"2012.05716v2","created_at":"2026-07-05T02:14:12.989767+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2012.05716","created_at":"2026-07-05T02:14:12.989767+00:00"},{"alias_kind":"pith_short_12","alias_value":"OZTP7DUMDPT2","created_at":"2026-07-05T02:14:12.989767+00:00"},{"alias_kind":"pith_short_16","alias_value":"OZTP7DUMDPT2RLDK","created_at":"2026-07-05T02:14:12.989767+00:00"},{"alias_kind":"pith_short_8","alias_value":"OZTP7DUM","created_at":"2026-07-05T02:14:12.989767+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":1,"internal_anchor_count":0,"sample":[{"citing_arxiv_id":"2605.09495","citing_title":"Enabling Structure-Only Initialization and Out-of-Distribution Generalization in GNN-based Molecular Dynamics Simulators","ref_index":166,"is_internal_anchor":false}]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ","json":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ.json","graph_json":"https://pith.science/api/pith-number/OZTP7DUMDPT2RLDK4T27QT4PMZ/graph.json","events_json":"https://pith.science/api/pith-number/OZTP7DUMDPT2RLDK4T27QT4PMZ/events.json","paper":"https://pith.science/paper/OZTP7DUM"},"agent_actions":{"view_html":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ","download_json":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ.json","view_paper":"https://pith.science/paper/OZTP7DUM","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2012.05716&json=true","fetch_graph":"https://pith.science/api/pith-number/OZTP7DUMDPT2RLDK4T27QT4PMZ/graph.json","fetch_events":"https://pith.science/api/pith-number/OZTP7DUMDPT2RLDK4T27QT4PMZ/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ/action/timestamp_anchor","attest_storage":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ/action/storage_attestation","attest_author":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ/action/author_attestation","sign_citation":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ/action/citation_signature","submit_replication":"https://pith.science/pith/OZTP7DUMDPT2RLDK4T27QT4PMZ/action/replication_record"}},"created_at":"2026-07-05T02:14:12.989767+00:00","updated_at":"2026-07-05T02:14:12.989767+00:00"}